Dr. Moses M. Kim, MD

Dr. Kim practices at Orange County Urology Associates, Inc. in Irvine, California.

Dr. Kim's NPI, 1972773604, was assigned on March 10, 2008. Dr. Kim graduated from UCSF School of Medicine in 2002. Dr. Kim holds California license A107538.

Dr. Kim's primary practice is Orange County Urology Associates, Inc., at 16305 Sand Canyon Ave, Irvine, CA 92618 in Orange County. The practice phone is (949) 855-1101.

Dr. Kim's primary practice is Orange County Urology Associates, Inc. in Irvine, California. Dr. Kim is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Orange County Urology Associates. Dmand AI also links Dr. Kim to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kim is board certified in urology by the American Board of Urology. Dmand AI has Dr. Kim's licenses on file in 2 states: California and Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Kim treats.

CMS data shows 6,985 Medicare services from Dr. Kim across 27 procedure codes in 2024, for 1,103 Medicare patients. Medicare paid $289,901 for them.

CMS counts 1,103 Medicare patients who saw Dr. Kim in 2024. The largest group is 65 to 74, with 466 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 74, with 11% women.

In 2024, Dr. Kim wrote 3,991 Medicare Part D claims for 1,050 patients. 92% of them were for generic drugs. CMS names the drug for 3,871 of them, across 27 drugs with 11 or more claims each, at $858,638 in total drug cost. In 2023, CMS named 3,731 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Kim for performance year 2024, reported as part of a group. Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kim as offering telehealth. CMS counts 37 procedures of prostate resection by Dr. Kim, more than 94% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Kim, published from 2022 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Cell Division, Prostatectomy and Prostatic Neoplasms. Dr. Kim has published most often in Urology. Dr. Kim's most frequent co-authors are Simone Crivellaro, MD, Ethan L. Ferguson, MD and Jihad H. Kaouk, MD.

CMS Open Payments shows 444 general payments to Dr. Kim from 39 drug and device companies from 2016 to 2025. Education make up the largest share, 63% of the total. Intuitive Surgical, Inc. paid the most, $140,809.

Dr. Kim graduated from UCSF School of Medicine in 2002.

Dr. Kim is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.